We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Testing Method Could Help More Patients Receive Right Cancer Treatment

By LabMedica International staff writers
Posted on 22 Mar 2024

Cancer treatment isn't always a one-size-fits-all solution, but the field of cancer research is making strides in matching patients with the most effective treatments for their specific conditions. More...

A groundbreaking study now points to a significant finding related to testing that could enable thousands of cancer patients to receive the precise treatment they need.

The research led by the University of Oklahoma (Oklahoma City, OK, USA) compared the effectiveness of immunohistochemistry (IHC) and next-generation sequencing (NGS) tests in newly diagnosed cancer patients to guide their treatment plans. These tests target the detection of high levels of microsatellite instability, a condition indicating the DNA's diminished capacity to correct replication errors. Identifying microsatellite instability is crucial, particularly in colon and endometrial cancer patients, as it marks a higher likelihood of a positive response to immunotherapy, which enhances the immune system's ability to fight cancer, compared to other treatments. IHC detects the absence of mismatch repair proteins responsible for correcting DNA copy errors, leading to microsatellite instability, while NGS assesses genetic mutations that indicate the same condition.

The analysis showed that NGS was more effective in identifying patients with microsatellite instability. Despite this, oncologists predominantly rely on IHC. The study suggests that adopting NGS, either alone or alongside IHC, could significantly increase the number of patients accurately diagnosed and appropriately treated for their cancer. For instance, in 2022, there were 151,030 new cases of colon cancer and 65,950 new cases of endometrial cancer diagnosed in the U.S. By utilizing NGS in conjunction with IHC, an additional 1,510 colon cancer cases and 3,891 endometrial cancer cases with microsatellite instability could have been identified, totaling 5,401 patients who might otherwise have been overlooked with IHC alone. This finding is expected to generate important discussions about whether to integrate NGS with or as an alternative to IHC testing for better patient care.

“This study has significant implications because, by changing the tests we use in certain situations, we anticipate that many more people can be accurately diagnosed and receive life-extending therapy,” said medical oncologist Abdul Rafeh Naqash from the University of Oklahoma who helped lead the study.

Related Links:
University of Oklahoma


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.